Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 17 Neoplasm Metastasis 8 Carcinoma, Non-Small-Cell Lung 6 Glioblastoma 5 Triple Negative Breast Neoplasms 4 Lymphoma, Mantle-Cell 4 Lymphoma, Follicular 4 Colorectal Neoplasms 4 Recurrence 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Neoplasms 3 Lymphoma, Large B-Cell, Diffuse 3 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumors 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Hereditary Sensory and Autonomic Neuropathies 2 Head and Neck Neoplasms 2 Endometrial Neoplasms 2 Brain Neoplasms 2 Waldenstrom Macroglobulinemia 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Tongue Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Salivary Gland Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pre-menopausal Breast Cancer 1

Interventions

NVP-BKM120 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pre-menopausal Breast Cancer × NVP-BKM120 × Clear all

NCT02058381 2020-03-09

B-YOND

Novartis

Phase 1 Completed

Pre-menopausal Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡